Ticker	Volume	Price	Price Delta
DJIA	12,454.80	-74.92	-0.60%
S&P 500	1,317.82	-2.86	-0.22%
Nasdaq	2,837.53	-1.85	-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,161.87	+5.35	0.25%
FTSE 100	5,351.53	+1.48	0.03%
DAX	6,339.94	+24.05	0.38%

Ticker	Volume	Price	Price Delta
Nikkei	8,580.39	+17.01	0.20%
TOPIX	722.11	-0.14	-0.02%
Hang Seng	18,713.40	+47.01	0.25%

Gold

1,571.20

+0.73%

EUR-USD

1.2517

-0.1227%

Nasdaq

2,837.53

-0.07%

DJIA

12,454.80

-0.60%

S&P 500

1,317.82

-0.22%

FTSE 100

5,351.53

+0.03%

STOXX 50

2,161.87

+0.25%

DAX

6,339.94

+0.38%

Oil (WTI)

90.86

+0.22%

U.S. 10-year

1.738%

-0.039

BAC:US

7.15

+0.14%

FB:US

31.91

-3.39%

Bloomberg

Exchange: -
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Generic Drugs

Actavis Group HF

ACT:IR

Acquired

Actavis Group HF (ACT:IR) was acquired by 0112654D:IR

Company Profile

ACTAVIS GROUP HF develops, manufactures, and sells generic pharmaceuticals. The Company offers generic pharmaceutical products for human use covering alimentary tract and metabolism, cardiovascular system, central nervous system, genito-urinary and sex hormones, and respiratory system. ACTAVIS supplies its products worldwide.